GVS S.p.A. (FRA:4YQ)
| Market Cap | 791.74M -3.7% |
| Revenue (ttm) | 422.13M -2.6% |
| Net Income | 27.97M +8.4% |
| EPS | 0.15 +2.6% |
| Shares Out | n/a |
| PE Ratio | 28.30 |
| Forward PE | 16.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 4.030 |
| Previous Close | 4.155 |
| Day's Range | 4.030 - 4.145 |
| 52-Week Range | 3.185 - 5.570 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 14, 2026 |
About GVS S.p.A.
GVS S.p.A., together with its subsidiaries, produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally. The company offers health and safety products, such as hand dryer and vacuum cleaner filters; nailstation COSMO products; fume extraction and HVAC building products; and disposable masks, half masks, integra masks, powered air purifying respirators, face fit testing, replacement filters, supplied air respirators, spare parts, and acc... [Read more]
Financial Performance
In 2025, GVS S.p.A.'s revenue was 424.66 million, a decrease of -0.91% compared to the previous year's 428.54 million. Earnings were 18.43 million, a decrease of -44.77%.
Financial StatementsNews
GVS S.p.A. Earnings Call Transcript: Q1 2026
Q1 2026 saw 3.9% organic revenue growth to €105 million, with adjusted EBITDA margin up 57 bps and net income at €10.7 million. Healthcare, Life Science, and Safety divisions led growth, while Mobility stabilized. Guidance remains for low single-digit sales growth and margin expansion.
GVS S.p.A. Earnings release: Q1 2026
GVS S.p.A. released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
GVS S.p.A. Slides: Q1 2026
GVS S.p.A. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
GVS S.p.A. Quarterly report: Q1 2026
GVS S.p.A. has published its Q1 2026 quarterly earnings report on May 14, 2026.
GVS S.p.A. Earnings Call Transcript: Q4 2025
Sales grew 2% year-over-year excluding FX, with adjusted EBITDA up 3% and margin at 25.2%. Guidance for 2026 is low single-digit growth, 20-50 bps EBITDA margin improvement, and a leverage ratio of 1.8, amid ongoing FX and raw material risks.
GVS S.p.A. Earnings release: Q4 2025
GVS S.p.A. released its Q4 2025 earnings on March 26, 2026, summarizing the period's financial results.
GVS S.p.A. Slides: Q4 2025
GVS S.p.A. has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 26, 2026.
GVS S.p.A. Annual report: Q4 2025
GVS S.p.A. has published its Q4 2025 annual report on March 26, 2026.
GVS S.p.A. Earnings Call Transcript: Q3 2025
Healthcare and life science and safety divisions delivered strong growth, while mobility faced headwinds. Adjusted EBITDA margin improved, and guidance for 2025 points to further margin expansion and cash generation, with new product launches and operational efficiencies expected to drive future growth.
GVS S.p.A. Earnings release: Q3 2025
GVS S.p.A. released its Q3 2025 earnings on November 12, 2025, summarizing the period's financial results.
GVS S.p.A. Slides: Q3 2025
GVS S.p.A. has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 12, 2025.
GVS S.p.A. Earnings Call Transcript: Q2 2025
Record EBITDA and margin expansion achieved, driven by core MedTech and Safety growth, price increases, and operational improvements. Guidance for mid-high single-digit revenue growth and further margin gains is confirmed, with strong cash generation and dividend planned by year-end.
GVS S.p.A. Earnings release: Q2 2025
GVS S.p.A. released its Q2 2025 earnings on August 7, 2025, summarizing the period's financial results.
GVS S.p.A. Slides: Q2 2025
GVS S.p.A. has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 7, 2025.